ArticleInternal medicine (Tokyo, Japan)2022

Addition of Baricitinib to COVID-19 Treatment Does Not Increase Bacterial Infection Compared to Standard Therapy: A Single-center Retrospective Study.

Hiroshi Kobe et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.